PRE 14A XBRL

PRE 14A Filing

Company: Cocrystal Pharma, Inc.
Filed: April 25, 2025
Period of Report: April 25, 2025
Accession Number: 0001641172-25-006222

View Document ↗ View on SEC.gov ↗